Skip to main content
Equibles

Deep Track Capital, LP

Position in ALGS — Aligos Therapeutics, Inc.

CIK 1856083 GREENWICH, CT
Back to ALGS Full portfolio

Position in ALGS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,562,514
-$737,223 QoQ
Shares Held
444,110
0.0% QoQ
Ownership
12.4%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1
of 31 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. ALGS ranks #57 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMVT
Immunovant, Inc.
 9,341,151 $359,914,548
2 GPCR
Structure Therapeutics Inc.
 4,740,072 $254,399,664
3 PCVX
Vaxcyte, Inc.
 4,300,000 $249,959,000
4 ALNY
Alnylam Pharmaceuticals, Inc.
 825,000 $248,349,750
5 MANE
Veradermics, Inc
 2,000,000 $245,880,000
6 TARS
Tarsus Pharmaceuticals, Inc.
 3,666,768 $230,786,377
7 OCUL
Ocular Therapeutix, Inc
 19,686,282 $193,319,289
8 BMRN
Biomarin Pharmaceutical Inc
 3,307,481 $189,254,062

All Filings in ALGS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,562,514 444,110
2026-03-31 $3,299,737 444,110
2025-12-31 $4,139,105 444,110
2025-09-30 $4,352,278 444,110
2025-06-30 $3,202,033 444,110
2025-03-31 $3,663,907 444,110
2024-12-31 $9,725,342 244,110
2024-09-30 $2,113,992 244,110
2024-06-30 $2,135,969 6,102,770
2024-03-31 $5,980,714 6,102,770
2023-12-31 $4,052,239 6,102,770